Can acyclovir raise warfarin (INR) or increase bleeding risk?
A direct, well-known interaction between acyclovir and warfarin is not commonly highlighted as a major “always avoid” drug-drug interaction. However, warfarin’s effect can still change during acyclovir treatment because acyclovir is cleared through the kidneys, and warfarin dosing is sensitive to changes in overall health and metabolism. If acyclovir contributes to kidney impairment, that can indirectly increase warfarin exposure and bleeding risk.
Why would the interaction happen indirectly?
A key pathway is renal function. Acyclovir is eliminated by the kidneys, and accumulation can occur in kidney impairment. When kidney function worsens, multiple drugs (including warfarin) can become harder to manage safely, and patients can also have changes in intake, illness severity, or medication adherence—all of which can push INR up or down.
What symptoms should patients watch for?
If the INR rises, bleeding can occur. Patients should watch for signs such as unusual bruising, bleeding gums, nosebleeds, blood in urine or stool, black/tarry stools, vomiting blood, or severe or persistent headache/dizziness (possible internal bleeding). Any serious bleeding should prompt urgent medical care.
What should clinicians do when a patient on warfarin needs acyclovir?
A common risk-control approach is to check INR more often when starting acyclovir and after any change in acyclovir dose or kidney function. Clinicians may also adjust warfarin based on INR results and review other contributors that affect INR (dietary vitamin K changes, antibiotics, alcohol intake, liver function, and adherence).
Does it matter whether acyclovir is oral vs IV?
Yes. IV acyclovir is more likely to be associated with acute kidney stress in some patients than oral therapy, especially in older adults or those with dehydration or pre-existing renal disease. That makes INR and bleeding risk monitoring more important in higher-risk settings (for example, hospitalized patients receiving IV acyclovir).
Are dose adjustments or renal monitoring relevant?
They can be. If a patient has reduced creatinine clearance, acyclovir dosing typically needs adjustment to avoid accumulation. Preventing acyclovir-induced kidney injury helps reduce the chance of INR becoming unpredictable during warfarin therapy.
Practical next step
If you’re asking because you or someone you’re caring for is on both medications, the safest immediate step is to contact the prescriber or anticoagulation clinic to confirm whether INR monitoring is needed now and what schedule to use. If kidney function is impaired or acyclovir is being started at higher doses (or given IV), ask specifically about more frequent INR checks.
Sources
No specific interaction-detail source was provided here. If you want, share which acyclovir formulation (oral vs IV), dose, and the patient’s kidney function (latest creatinine/eGFR) and I can tailor the interaction-risk reasoning more precisely.